Nonalcoholic fatty liver disease in India - a lot done, yet more required! (Q37824619)

23 August 2017

1 reference

title

Nonalcoholic fatty liver disease in India - a lot done, yet more required! (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

23 August 2017

0 references

0 references

1 reference

1 reference

Ajay Duseja

1

1 reference

PubMed ID

21191681

23 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

Indian Journal of Gastroenterology

23 August 2017

1 reference

23 August 2017

29

1 reference

23 August 2017

217-225

1 reference

23 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s12664-010-0069-1

23 August 2017

0 references

cites work

Clinical features and natural history of nonalcoholic steatosis syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Impaired fasting glucose and impaired glucose tolerance in urban population in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Non-alcoholic steatohepatitis in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Cytokines in alcoholic and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Guidelines for healthy weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

BMI does not accurately predict overweight in Asian Indians in northern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Investigation of hepatic gluconeogenesis pathway in non-diabetic Asian Indians with non-alcoholic fatty liver disease using in vivo ((31)P) phosphorus magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Macaca radiata (bonnet monkey): a spontaneous model of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-010-0069-1

Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions.

21 January 2018

1 reference

12 December 2020

Nonalcoholic steatohepatitis: clinicopathological profile

1 reference

12 December 2020

Asians need different criteria for defining overweight and obesity

1 reference

12 December 2020

Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease.

1 reference

12 December 2020

Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).

1 reference

12 December 2020

Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values.

1 reference

12 December 2020

Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis.

1 reference

12 December 2020

The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West

1 reference

12 December 2020

Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)

1 reference

12 December 2020

Adipose tissue transplantation may be a potential treatment for diabetes, atherosclerosis and nonalcoholic steatohepatitis

1 reference

12 December 2020

Clinical, biochemical and histological profile of nonalcoholic steatohepatitis

1 reference

12 December 2020

Unconjugated hyperbilirubinemia in nonalcoholic steatohepatitis--is it Gilbert's syndrome?

1 reference

12 December 2020

Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis

1 reference

12 December 2020

A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.

1 reference

12 December 2020

Prevalence of non-alcoholic fatty liver disease: population based study.

1 reference

12 December 2020

Dyslipidemia in Asian Indians: determinants and significance

1 reference

12 December 2020

Asian indians and insulin resistance syndrome: global perspective

1 reference

12 December 2020

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

1 reference

12 December 2020

Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey.

1 reference

12 December 2020

AGA technical review on nonalcoholic fatty liver disease

1 reference

12 December 2020

Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

Serum iron levels and hepatic iron overload in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic fatty liver in a developing country is responsible for significant liver disease

1 reference

12 December 2020

Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis--a preliminary report.

1 reference

12 December 2020

Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease.

1 reference

12 December 2020

Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management.

1 reference

12 December 2020

How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?

1 reference

12 December 2020

Nonalcoholic fatty liver disease in India--how much? How soon?

1 reference

12 December 2020

Clinicopathological profile of hepatic involvement in type-2 diabetes mellitus and its significance.

1 reference

12 December 2020

Nonalcoholic fatty liver disease in India--is it different?

1 reference

12 December 2020

Spectrum of histological features in non-alcoholic fatty liver disease

1 reference

12 December 2020

Chronic liver disease in diabetes mellitus.

1 reference

12 December 2020

Role of polymerase chain reaction and liver biopsy in the evaluation of patients with asymptomatic transaminitis: implications in diagnostic approach

1 reference

12 December 2020

10.1007/S12664-010-0069-1

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21191681